Skip to main content

Nonprofit · EIN 84-4147678

HIV AND HEPATITIS POLICY INSTITUTE

Tax-exempt · WASHINGTON, DC 20009

Financials

$1.3M$1M2023$1.3M$1.2M2024
Revenue Expenses · by fiscal year end
Financials of HIV AND HEPATITIS POLICY INSTITUTE by year, from its e-filed returns
Year endedFormRevenueExpensesNet incomeTotal assetsLiabilitiesNet assets
December 31, 2024990$1,275,492$1,237,114$38,378$1,136,070$0$1,136,070
December 31, 2023990$1,313,570$1,037,874$275,696$1,097,692$0$1,097,692
Financial details: 990 for the year ended December 31, 2024

Revenue

Contributions, gifts and grants
$1,262,500
Membership dues
$797,500
Program service revenue
$0
Investment income
$12,992
Other revenue
$0

Expenses

Grants and similar amounts paid
$0
Compensation of officers, directors and key employees
$271,247
Other salaries and wages
$331,064
Salaries, compensation and benefits (total)
$728,782
Professional fundraising fees
$0
Legal fees
$4,370
Accounting fees
$9,494
Occupancy
$3,398
Travel
$8,596
Program services (functional)
$1,072,068
Management and general (functional)
$148,607
Fundraising (functional)
$16,439

Balance sheet and other

Total assets, start of year
$1,097,692
Total assets, end of year
$1,136,070
Total liabilities, end of year
$0
Net assets, end of year
$1,136,070
Net assets without donor restrictions
$1,136,070
Gross receipts
$1,275,492
Employees
6
Year formed
2019
State of legal domicile
DC

From the e-filed returns the IRS publishes as XML (latest three processing years; amended returns replace the original). PDF copies at the IRS.

Officers, directors and key employees

As listed on the 990 for the year ended December 31, 2024, highest compensation first.

NameTitleHours / weekCompensationOther / benefits
CARL E SCHMID IIPRESIDENT/EX
Trustee or director, Officer
60$271,247$29,155
KEVIN HERWIGHEALTH POLIC
Highest-paid employee
40$135,000$19,563
ERIN DARLINGDIRECTOR
Trustee or director
–$0$0
MARC MEACHEMDIRECTOR
Trustee or director
–$0$0
JUSTIN C SMITH MS MPHSECRETARY/DI
Trustee or director, Officer
–$0$0
RAFAELE NARVAEZDIRECTOR
Trustee or director
–$0$0
REKHA RAMESHTREASURER/DI
Trustee or director, Officer
–$0$0
ANDREW SPERLINGVICE PRESIDE
Trustee or director
–$0$0
PAM TRAXELDIRECTOR
Trustee or director
–$0$0
STEVEN R YOUNGDIRECTOR
Trustee or director
–$0$0
990 for the year ended December 31, 2023: 10 people
NameTitleHours / weekCompensationOther / benefits
CARL E SCHMID IIPRESIDENT/EX
Trustee or director, Officer
60$256,758$48,243
KEVIN HERWIGHEALTH POLIC
Highest-paid employee
40$125,000$16,963
ERIN DARLINGDIRECTOR
Trustee or director
–$0$0
MARC MEACHEMDIRECTOR
Trustee or director
–$0$0
JUSTIN C SMITH MS MPHSECRETARY/DI
Trustee or director, Officer
–$0$0
RAFAELE NARVAEZDIRECTOR
Trustee or director
–$0$0
REKHA RAMESHTREASURER/DI
Trustee or director, Officer
–$0$0
ANDREW SPERLINGVICE PRESIDE
Trustee or director
–$0$0
PAM TRAXELDIRECTOR
Trustee or director
–$0$0
STEVEN R YOUNGDIRECTOR
Trustee or director
–$0$0

Address and contacts

Address (IRS master file)
1602 BELMONT ST NW APT B, WASHINGTON, DC 20009-6546
In care of
% CARL E SCHMID II
Principal officer (990 for 2024)
CARL E SCHMID II, 1602B BELMONT ST NW, APT 2, WASHINGTON, DC 20009
Signed the 990
CARL E SCHMID II, PRESIDENT/EXEC DIR
Phone
(202) 462-3042
Return prepared by
ALINE ACCOUNTING PARTNERS DBA EUBANKS AC

Mission

THE HIV+HEPATITIS POLICY INSTITUTE PROMOTES QUALITY AND AFFORDABLE HEALTHCARE FOR PEOPLE LIVING WITH OR AT RISK OF HIV, HEPATITIS, AND OTHER SERIOUS AND CHRONIC HEALTH CONDITIONS. MONITORS POLICIES THAT IMPACT THE PREVENTION AND TREATMENT OF HIV, VIRAL HEPATITIS, AND OTHER HEALTH CONDITIONS IN THE UNITED STATES. COMMUNICATES WITH MEMBERS OF THE HIV, HEPATITIS, AND OTHER PATIENT GROUP COMMUNITIES ON KEY POLICY ISSUES THAT IMPACT THEIR ACCESS TO HEALTHCARE. EDUCATES POLICYMAKERS AND MEMBERS OF THE MEDIA ABOUT EFFORTS TO END BOTH HIV AND HEPATITIS IN THE UNITED STATES AND TO IMPROVE ACCESS TO QUALITY AND AFFORDABLE HEALTHCARE FOR PEOPLE WITH OR AT RISK OF SERIOUS OR CHRONIC HEALTH CONDITIONS.

990 for the year ended December 31, 2024

Program accomplishments

  • HIV: HIV+HEP CARRIED OUT ACTIVITIES THAT ADVANCE POLICIES AND PROGRAMS THAT INCREASE HIV PREVENTION AND TREATMENT, INCLUDING THE RYAN WHITE HIV/AIDS PROGRAM AND THE ACTIVITIES OF THE CENTERS FOR DISEASE CONTROL AND PREVENTION HIV DIVISION. AS THE FEDERAL GOVERNMENT CONTINUES TO FOCUS ON ACTIVITIES TO END HIV IN THE UNITED STATES, HIV+HEP PARTICIPATED IN ONGOING OPPORTUNITIES TO DEVELOP AND IMPLEMENT THE PROGRAMS AND POLICIES TO ACHIEVE THE GOALS OF THE INITIATIVE. ONE AREA OF FOCUS WAS PRE-EXPOSURE PROPHYLAXIS (PREP), A DRUG THAT PREVENTS HIV, INCLUDING PRIVATE INSURANCE COVERAGE, ZERO PATIENT COST-SHARING OBLIGATIONS BY INSURERS, AND THE CREATION OF A NATIONAL PREP PROGRAM. WE RESPONDED TO MANY COMPLAINTS BY PREP USERS WHO WERE BEING ILLEGALLY CHARGED COST-SHARING FOR PREP OR THE ASSOCIATED LABS AND HELPED THEM WITH THEIR INSURERS AND REGULATORS. WE BROUGHT THIS ONGOING ISSUE TO POLICYMAKERS AND THE MEDIA. WE ALSO MONITORED A LEGAL CASE THAT CHALLENGED THE PREVENTIVE SERVICES COVERAGE REQUIREMENTS INCLUDED IN THE AFFORDABLE CARE ACT. HIV+HEP WORKED TO ENSURE ACCESS TO ALL ANTIRETROVIRALS TO TREAT HIV IN THE MEDICARE PART D PROGRAM AND THE PRIVATE INSURANCE MARKET. WE REVIEWED INSURANCE BENEFIT DESIGN TO ENSURE PLANS WERE COMPLIANT WITH THE ACA AND FILED COMPLAINTS WITH SEVERAL STATE INSURANCE REGULATORS. AS PART OF ALL ITS WORK IT ENSURED THAT THE POLICIES AND PROGRAMS BEST MEET THE NEEDS OF THOSE HIGHLY IMPACTED BY HIV. HIV+HEP SPOKE AT NUMEROUS HIV MEETINGS AND WEBINARS, SUBMITTED PUBLIC COMMENTS AND TESTIMONY, ISSUED PRESS RELEASES, RESPONDED TO MEDIA INQUIRIES, AND CONDUCTED OTHER MEDIA ACTIVITIES. THIS WORK WAS CONDUCTED ON ITS OWN AND IN COALITION WITH OTHERS, INCLUDING THE WORKGROUPS OF THE FEDERAL AIDS POLICY PARTNERSHIP.
    Expenses $539,775
  • HEPATITIS: HIV+HEP CARRIED OUT ACTIVITIES THAT ADVANCE POLICIES AND PROGRAMS THAT INCREASE VIRAL HEPATITIS PREVENTION AND TREATMENT, INCLUDING THE ACTIVITIES OF THE CENTERS FOR DISEASE CONTROL AND PREVENTION VIRAL HEPATITIS DIVISION. THE PRINCIPAL FOCUS OF HIV+HEP'S ACTIVITIES WAS TO ENSURE THERE ARE SUFFICIENT RESOURCES FOR STATES AND COMMUNITY-BASED ORGANIZATIONS TO OFFER HEPATITIS TESTING, CONDUCT SURVEILLANCE, AND LINK PEOPLE WITH HEPATITIS TO HEALTHCARE AND THE TREATMENT THEY NEED TO MAINTAIN THEIR HEALTH OR IN THE CASE OF HEPATITIS C, TO BE CURED. HIV+HEP OFFERED COMMENTS ON THE ADMINISTRATION'S PROPOSAL TO END HEPATITIS C. HIV+HEP SUBMITTED PUBLIC COMMENTS AND TESTIMONY, ISSUED PRESS RELEASES, RESPONDED TO MEDIA INQUIRIES, AND CONDUCTED OTHER MEDIA ACTIVITIES. THIS WORK WAS CONDUCTED ON ITS OWN AND IN COALITION WITH OTHERS, INCLUDING THE HEPATITIS APPROPRIATIONS COALITION.
    Expenses $122,670
  • GENERAL HEALTHCARE ACCESS: HIV+HEP WORKED TO ENSURE PEOPLE LIVING WITH SERIOUS AND CHRONIC HEALTH CONDITIONS HAVE ACCESS TO AFFORDABLE HEALTHCARE, INCLUDING PRESCRIPTION DRUGS. THIS INCLUDED POLICY ANALYSIS IN THE AREAS OF MEDICAID, MEDICARE, AND PRIVATE INSURANCE. HIV+HEP EDUCATED THE PATIENT COMMUNITY, THE MEDIA, AND POLICYMAKERS AT THE FEDERAL AND STATE LEVELS, ON THE IMPORTANCE OF COPAY ASSISTANCE FOR PRESCRIPTION DRUGS. WE SUCCESSFULLY WON A LEGAL CHALLENGE OF THE FEDERAL REGULATION THAT ALLOWS INSURERS TO IMPLEMENT COPAY ACCUMULATOR PROGRAMS AND URGED THE FEDERAL GOVERNMENT TO COMPLY WITH THE COURT'S DECISION. HIV+HEP ALSO PARTICIPATED IN THE ACTIVITIES OF THE NATIONAL ASSOCIATION OF INSURANCE COMMISSIONERS, WHERE WE FOCUSED ON THE IMPACT OF PHARMACY BENEFIT MANAGERS ON PATIENT ACCESS AND AFFORDABILITY OF PRESCRIPTION DRUGS, PRIOR AUTHORIZATION PROCESSES, AND COVERAGE OF PREVENTIVE SERVICES. HIV+HEP SUBMITTED COMMENTS ON PROPOSED EXECUTIVE AGENCY REGULATIONS, ISSUED PRESS RELEASES AND RESPONDED TO MEDIA INQUIRIES, AND PRESENTED BEFORE PATIENT GROUPS. THIS WORK WAS PERFORMED ON ITS OWN AND IN COALITION WITH OTHER PATIENT GROUPS, INCLUDING THE PARTNERSHIP FOR PART D, MEDICARE ACCESS FOR PATIENTS RX (MAPRX), AND ALL COPAYS COUNT COALITION.
    Expenses $409,623

What it must file and when

IRS records say it files Form 990 or 990-EZ. Based on its last return; a smaller organization may file the 990-N. Its accounting year ends in December, so each return is due on the 15th day of the 5th month after that.

Tax yearYear endedDueIRS public records
2025December 31, 2025May 15, 2026Not on file
2024December 31, 2024May 15, 2025990 on file
2023December 31, 2023May 15, 2024990 on file

IRS record

EIN
84-4147678
Tax-exempt status
501(c)(3): Charitable, religious, educational or scientific organization
Foundation status
Publicly supported organization (170(b)(1)(A)(vi))
Donations deductible (Pub 78)
Public charity, 50% deduction limit
Exempt since
2021
Accounting year ends
December
Files
Form 990 or 990-EZ
Category (NTEE)
Health care (E05)
Assets (IRS master file)
$1,136,070
Income (IRS master file)
$1,275,492

Filing history

FormYear endedRevenueExpensesAssetsReturn
990December 2024$1,275,492$1,237,114$1,136,070IRS
990December 2023$1,313,570$1,037,874$1,097,692XML
990December 2022$1,257,550$1,148,591$821,996IRS
990December 2021–––IRS
990December 2020–––IRS

990-N: the IRS bulk file holds only the latest e-Postcard per organization; earlier years come from archived copies of that file since 2020 and can have gaps (the IRS e-Postcard search lists every one). 990, 990-EZ, 990-PF, 990-T: every e-filed return in the IRS e-file index since 2019; XML for the latest three processing years, amounts from the IRS Statistics of Income extracts before that. PDF copies and determination letters at the IRS (search EIN 84-4147678).

Questions about HIV AND HEPATITIS POLICY INSTITUTE

What is the EIN of HIV AND HEPATITIS POLICY INSTITUTE?
The employer identification number (EIN) of HIV AND HEPATITIS POLICY INSTITUTE is 84-4147678.
Is HIV AND HEPATITIS POLICY INSTITUTE tax-exempt?
Yes. The IRS lists it as tax-exempt under section 501(c)(3) since 2021.
Are donations to HIV AND HEPATITIS POLICY INSTITUTE tax-deductible?
Yes. It is listed in IRS Publication 78 (Public charity, 50% deduction limit).
Which annual return does HIV AND HEPATITIS POLICY INSTITUTE file?
Form 990 or 990-EZ. Based on its last return; a smaller organization may file the 990-N.
When is the next return of HIV AND HEPATITIS POLICY INSTITUTE due?
The return for tax year 2025 (the year ending December 31, 2025) is due May 15, 2026. Form 8868 extends it by six months; the 990-N cannot be extended.
When did HIV AND HEPATITIS POLICY INSTITUTE last file with the IRS?
The latest return in the IRS public files is the 990 for the year ended December 2024.
Who is the principal officer of HIV AND HEPATITIS POLICY INSTITUTE?
The 990 for the year ended December 31, 2024 names CARL E SCHMID II.
Who are the officers and directors of HIV AND HEPATITIS POLICY INSTITUTE?
The 990 for the year ended December 31, 2024 lists 10 people; 2 received compensation from the organization, the highest $271,247 (CARL E SCHMID II, PRESIDENT/EX).
How much revenue does HIV AND HEPATITIS POLICY INSTITUTE have?
On its 990 for the year ended December 31, 2024 it reported revenue of $1,275,492, expenses of $1,237,114 and total assets of $1,136,070 at year end.

Other nonprofits in WASHINGTON

All nonprofits in WASHINGTON · District of Columbia · Health care